CI
50
-3
KMB
40
-4
NWS
86
3
SWN
42
-4
SO
66
-7
NAVI
33
-5
BF.B
48
-5
AIZ
57
-7
KMI
61
-2
GLW
61
-2
IVZ
52
-4
JCI
32
-3
GS
70
4
A
37
-3
ITW
58
-4
XRAY
16
-3
VLO
40
5
LRCX
77
6
GILD
47
-3
ETR
49
-3
CI
50
-3
KMB
40
-4
NWS
86
3
SWN
42
-4
SO
66
-7
NAVI
33
-5
BF.B
48
-5
AIZ
57
-7
KMI
61
-2
GLW
61
-2
IVZ
52
-4
JCI
32
-3
GS
70
4
A
37
-3
ITW
58
-4
XRAY
16
-3
VLO
40
5
LRCX
77
6
GILD
47
-3
ETR
49
-3
Financhill
Back

Biodexa Pharmaceuticals Plc Quote, Financials, Valuation and Earnings

This New Idea is Set to Shock the World

Click here to learn all the details.
Sell
25

BDRX
Biodexa Pharmaceuticals Plc

Last Price:
0.84
Seasonality Move:
-5.55%

7 Day Trial

ALL ACCESS PASS

$ 7

The Next Nvidia?

Go here now for this breaking story.

Biodexa Pharmaceuticals Plc Price Quote

$0.84
-0.03 (-3.68%)
(Updated: June 26, 2024 at 11:36 AM ET)

Biodexa Pharmaceuticals Plc Key Stats

Sell
25
Biodexa Pharmaceuticals Plc (BDRX) is a Sell
Day range:
$0.86 - $0.93
52-week range:
$0.67 - $9.74
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.74
P/B ratio:
1.33%
Volume:
272.5K
Avg. volume:
5M
1-year change:
-83.73%
Market cap:
$7.9M
Revenue:
$474.1K
EPS:
$-402

How Much Does Biodexa Pharmaceuticals Plc Make?

Is Biodexa Pharmaceuticals Plc Growing As A Company?

Data Unavailable

Biodexa Pharmaceuticals Plc Stock Price Performance

What Is Biodexa Pharmaceuticals Plc 52-Week High & Low?

Biodexa Pharmaceuticals Plc Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Biodexa Pharmaceuticals Plc?

Is Biodexa Pharmaceuticals Plc Cash Flow Positive?

  • What Is BDRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$8.5M
  • What Is Biodexa Pharmaceuticals Plc’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $12.8M
  • What Is Biodexa Pharmaceuticals Plc’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$328.9K

Biodexa Pharmaceuticals Plc Return On Invested Capital

  • Is Management Doing A Good Job?
    BDRX return on invested capital is -160.77%
  • What Is Biodexa Pharmaceuticals Plc Return On Assets?
    ROA measures how assets are converting to revenues and is -87.8%
  • What Is BDRX Return On Equity?
    ROE is a measure of profitability and is -160.77%

Biodexa Pharmaceuticals Plc Earnings Date & Stock Price

Biodexa Pharmaceuticals Plc Competitors

Biodexa Pharmaceuticals Plc Dividend Yield

Data Unavailable

Biodexa Pharmaceuticals Plc Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.02
Upside from Last Price: 819.07%

Major Shareholders

  • How many BDRX shares are owned by institutional investors?
    46.2K BDRX shares are owned by institutional investors
  • How many BDRX shares are owned by insiders?
    1.3M BDRX shares are owned by insiders